A clinical trial to study the effect of drug, buprenorphine by administering through 2 route(intravenous and epidural) in patient for pain management following abdominal surgery
Phase 4
- Conditions
- Health Condition 1: K318- Other specified diseases of stomach and duodenum
- Registration Number
- CTRI/2022/10/046510
- Lead Sponsor
- DR YOUVARAJ M
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Consent to participate in study
2. ASA grade I & II
3. Patients scheduled for abdominal surgery
Exclusion Criteria
1. Uncooperative patient/not able to understand pain assessment test
2. History of allergy or sensitivity or any other reaction to the study drug
3. History of any significant neurological, pulmonary, cardiovascular, hepatorenal, psychiatric, metabolic disease
4. parturient and lactating women
5. Bleeding diathesis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Epidural Buprenorphine provides better quality and prolonged duration of analgesia postoperativeTimepoint: 24weeks
- Secondary Outcome Measures
Name Time Method Buprenorphine is better narcotics and produces less side effects as compared to other opioidsTimepoint: 24weeks